Skip to main content
. 2021 Mar 6;13(3):344. doi: 10.3390/pharmaceutics13030344

Figure 6.

Figure 6

DSC (a), PXRD (b), and FT-IR (c) profiles of samples: (A) RXB, (B) PVP VA64, (C) Cremophor® RH 40, (D) physical mixture, and (E) optimized RXB-ASD.